Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Int Immunopharmacol ; 4(10-11): 1401-8, 2004 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-15313437

RESUMO

The carrageenan model of pleurisy is described as temporal plasma exudation (1-5 h) with extensive neutrophil infiltration and release of proteinases into the pleural cavity. The aim of this work was to study the effects of serine proteinase inhibitors on the inflammatory process induced by administration of carrageenan to the rat pleural cavity and on release of kinins in pleural exudate. Pleurisy was induced by injecting carrageenan and serine proteinase inhibitors simultaneously into the pleural cavity. The proteinase inhibitors used were: aprotinin, a plasma kallikrein inhibitor; recombinant leech derived tryptase inhibitor-2PL (LDTI-2PL), a plasmin inhibitor; Boophilus microplus trypsin inhibitors (BmTIs); trypsin; plasma kallikrein; plasmin and neutrophil elastase inhibitors; and a synthetic neutrophil elastase inhibitor (EIsynt). Administration of carrageenan with LDTI-2PL and BmTIs induced a marked increase in exudation (143% and 201%) and leukocyte migration (288% and 408%), respectively, when compared to the control group. Pleural exudate from LDTI-2PL and BmTIs plus carrageenan-treated rats showed a significant increase in plasma kallikrein-like activity, measured by chromogenic substrate hydrolysis. The specific inhibition of enzymatic activity with aprotinin confirmed that 50% of S2302 hydrolysis was produced by plasma kallikrein-like enzymes. Kinin release was increased by 97% and 103% in exudates from LDTI-2PL and BmTIs plus carrageenan-treated rats, respectively. Considering that the plasmin inhibitors LDTI-2PL and BmTIs increased exudation, leukocyte migration and bradykinin release, our results suggest an anti-inflammatory role for plasmin in the pleurisy model.


Assuntos
Bradicinina/metabolismo , Pleurisia/metabolismo , Inibidores de Serina Proteinase/farmacologia , Animais , Carragenina , Quimiotaxia de Leucócito/efeitos dos fármacos , Exsudatos e Transudatos/metabolismo , Fibrinolisina/antagonistas & inibidores , Fibrinolisina/metabolismo , Ixodidae , Sanguessugas , Masculino , Pleurisia/induzido quimicamente , Radioimunoensaio , Ratos , Ratos Wistar
2.
Int Immunopharmacol ; 2(4): 557-63, 2002 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-11962734

RESUMO

Boophilus microplus trypsin inhibitors (BmTIs) present in larvae were preliminarily characterized as active proteins, approximately 10-18 kDa, by SDS-PAGE. BmTIs showed trypsin inhibitory activity on reverse zymography containing gelatin (0.03%) and also inhibited others serine proteinases (human neutrophil elastase and human plasma kallikrein). Bos indicus, Nelore breed calves, previously sensitized with BmTIs and challenged with tick larvae (20,000 larvae/animal), showed 72.8% efficacy to interfere in tick development with 69.7% and 71.3% reduction of both tick number and egg weight, respectively. Cattle BmTls antiserum titer was approximately 1:8000. The maximum level of BmTls antibody production was detected 40 days after the first immunization by ELISA. Our preliminary results suggest that B. microplus serine proteinase inhibitors may play a role in the tick larvae fixation and feeding processes. Therefore, the development of antibodies against BmTIs might impair the normal parasitism.


Assuntos
Antígenos/imunologia , Bovinos/imunologia , Infestações por Carrapato/prevenção & controle , Infestações por Carrapato/veterinária , Carrapatos/imunologia , Inibidores da Tripsina/imunologia , Animais , Anticorpos/imunologia , Eletroforese em Gel de Poliacrilamida , Imunização/métodos , Imunização/veterinária , Larva/imunologia , Infestações por Carrapato/imunologia , Infestações por Carrapato/parasitologia , Carrapatos/crescimento & desenvolvimento , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA